Family Medicine Doctors in Parsons, KS Accepting Medicare

11 Family Medicine doctors found. Showing 1 - 11

Sonya K Culver, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Us Highway 59, Ste 4, Parsons, KS 67357 Phone: 620-421-2700    Fax: 620-421-8135

Arun L Sharma, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1509 Main Street, Parsons, KS 67357 Phone: 620-421-0600    Fax: 620-421-8476

Shelbie Cosby, DNP STUDENT Family Medicine Medicare: Medicare Enrolled Practice Location: 1902 S Us Highway 59, Parsons, KS 67357 Phone: 620-820-4881

Earl G Cornell, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1509 Main Street, Parsons, KS 67357 Phone: 620-421-0600    Fax: 620-421-8476

Jimmy V Buller, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1509 Main St, Parsons, KS 67357 Phone: 620-423-3307    Fax: 620-423-3329

Dr. John E. Hetlinger, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Hwy 59 Bldg E, Suite 101, Parsons, KS 67357 Phone: 620-820-5800    Fax: 620-820-5589

Dr. Elaina Hope Murray, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Us Highway 59, Parsons, KS 67357 Phone: 620-820-5800

Dr. Gary Yarbrough, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1721 Main Street, Parsons, KS 67357 Phone: 620-421-3011

Kayla Daniels, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Us Highway 59, Parsons, KS 67357 Phone: 620-421-4881

Andrea K Willhite, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1902 S Hwy 59 Bldg E, Parsons, KS 67357 Phone: 620-820-5800    Fax: 620-820-5589

Dr. Rema S Menon, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 2601 Gabriel Ave, Parsons, KS 67357 Phone: 620-421-6550    Fax: 620-421-1525

News Archive

BerGenBio AS starts Phase 1 Clinical Trial for BGB324 oral AXL inhibitor

BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB324 is a single ascending dose study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BGB324.

Researchers suggest that fibromyalgia is a spectrum disorder

Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness.

Salk researchers find that the brain's capacity for storing new memories is dynamic

Those of us who can't resist tourist tchotchkes are big fans of suitcases with an expandable compartment. Now, it turns out the brain's capacity for storing new memories is expandable, too, with limitations.

Researchers elucidate role of mutations in deadly brain cancer

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center have discovered how different mutations in a specific gene help drive glioblastoma, the most lethal form of brain cancer.

Read more Medical News

› Verified 2 days ago